Old Web
English
Sign In
Acemap
>
Paper
>
E35Efficacy and safety of immune checkpoint inhibitor nivolumab and radiotherapy combination in advanced NSCLC
E35Efficacy and safety of immune checkpoint inhibitor nivolumab and radiotherapy combination in advanced NSCLC
2017
L Belluomini
Francesco Fiorica
A. Stefanelli
A. Santini
Benedetta Urbini
F. Daniel
L R Martella
I. Toma
F Lancia
A. Moretti
E. Bannò
Carlotta Giorgi
Antonio Frassoldati
Keywords:
General surgery
Medicine
Nivolumab
Cancer research
Immune checkpoint
Radiation therapy
Internal medicine
Pathology
Oncology
immune checkpoint inhibitors
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]